Literature DB >> 10225835

Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid.

F P Kroon1, M J van Tol, C M Jol-van der Zijde, R van Furth, J T van Dissel.   

Abstract

In human immunodeficiency virus (HIV)-infected individuals the amount of antibodies formed after vaccination with T-cell-dependent recall antigens such as tetanus toxoid is proportional to the peripheral blood CD4(+) T-lymphocyte counts. To investigate whether the immunoglobulin G (IgG) subclass distribution and avidity of the antibodies produced after vaccination are affected as well, we gave 13 HIV-infected adults with low CD4(+) T-lymphocyte counts (<200 x 10(6)/liter; group I), 11 HIV-infected adults with intermediate CD4(+) T-lymphocyte counts (>/=200 x 10(6)/liter; group II), and 5 healthy controls booster immunizations with tetanus toxoid. The prevaccination antibody concentrations against tetanus toxoid were similar in the HIV-infected and healthy adults. After vaccination the total IgG and the IgG1 anti-tetanus toxoid antibody concentrations were significantly lower in group I than in group II and the controls. The avidity of the IgG1 anti-tetanus toxoid antibodies formed by HIV-infected adults was within the range for healthy controls, irrespective of their CD4(+) T-lymphocyte counts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225835      PMCID: PMC103722          DOI: 10.1128/CDLI.6.3.352-355.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen.

Authors:  E Yefenof; V M Sanders; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

2.  The biolgoical significance of antibody affinity.

Authors:  M W Steward
Journal:  Immunol Today       Date:  1981-07

3.  Antibody avidity determination by ELISA using thiocyanate elution.

Authors:  G R Pullen; M G Fitzgerald; C S Hosking
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

4.  Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.

Authors:  E J Gerritsen; M J Van Tol; M B Van 't Veer; J M Wels; I M Khouw; C R Touw; C M Jol-Van Der Zijde; J Hermans; H C Rümke; J Radl
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

5.  The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity.

Authors:  P Bird; J Lowe; R P Stokes; A G Bird; N R Ling; R Jefferis
Journal:  J Immunol Methods       Date:  1984-06-08       Impact factor: 2.303

6.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.

Authors:  F P Kroon; J T van Dissel; J Labadie; A M van Loon; R van Furth
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG.

Authors:  E N Janoff; W D Hardy; P D Smith; S M Wahl
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.

Authors:  F P Kroon; J T van Dissel; J C de Jong; R van Furth
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

10.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18
View more
  7 in total

Review 1.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 2.  Tetanus in Ethiopia: unveiling the blight of an entirely vaccine-preventable disease.

Authors:  Yohannes Woubishet Woldeamanuel
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

3.  Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.

Authors:  C T Burton; R L Goodall; A Samri; B Autran; A D Kelleher; G Poli; G Pantaleo; F M Gotch; N Imami
Journal:  Clin Exp Immunol       Date:  2008-05       Impact factor: 4.330

4.  Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.

Authors:  Anselmo Souza; Silvane Santos; Lucas P Carvalho; Maria Fernanda R Grassi; Edgar M Carvalho
Journal:  Hum Immunol       Date:  2016-06-06       Impact factor: 2.850

5.  CD20 deficiency in humans results in impaired T cell-independent antibody responses.

Authors:  Taco W Kuijpers; Richard J Bende; Paul A Baars; Annette Grummels; Ingrid A M Derks; Koert M Dolman; Tim Beaumont; Thomas F Tedder; Carel J M van Noesel; Eric Eldering; René A W van Lier
Journal:  J Clin Invest       Date:  2009-12-21       Impact factor: 14.808

6.  Identification of antigen-specific B cell receptor sequences using public repertoire analysis.

Authors:  Johannes Trück; Maheshi N Ramasamy; Jacob D Galson; Richard Rance; Julian Parkhill; Gerton Lunter; Andrew J Pollard; Dominic F Kelly
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

7.  Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.

Authors:  Y K Onno Teng; Robert J Verburg; Kirsten N Verpoort; Gwendolyn M P Diepenhorst; Ingeborg M Bajema; Maarten J D van Tol; Els C M Jol-van der Zijde; Rene E M Toes; Tom W J Huizinga; Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.